PEA
BSX icon

Park Edge Advisors’s Boston Scientific BSX Stock Holding History

Park Edge Advisors’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-16,958
Closed -$1.06M – 156
2026
Q1 		$1.06M Buy
+16,958
New +$1.36M 0.25% 69
2023
Q3 		– Sell
-18,542
Closed -$1M – 103
2023
Q2 		$1M Sell
18,542
-1,708
-8% -$89.2K 0.34% 30
2023
Q1 		$1.01M Buy
20,250
+3,791
+23% +$179K 0.39% 28
2022
Q4 		$762K Buy
+16,459
New +$713K 0.33% 32

Other funds holding BSX

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
FFM
Fisher Funds Management Auckland, New Zealand $3.52B AUM 17.59% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
ZIC
ZWJ Investment Counsel Atlanta, Georgia $3.09B AUM 39.43% 1-Year Est. Return
GI
Gradient Investments Arden Hills, Minnesota $7.25B AUM 20.71% 1-Year Est. Return
OIAM
OFI Invest Asset Management Paris, France $10B AUM 48.47% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return

Park Edge Advisors's BSX Position: Q2 2026 in Review

Park Edge Advisors sold out of Boston Scientific (BSX) in Q2 2026, closing a stake of 16,958 shares — an estimated $1.06M sold.

Park Edge Advisors first reported a position in BSX in Q4 2022 and held it in 4 quarters. The position peaked at $1.06M in Q1 2026. 179 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Park Edge Advisors reported no remaining Boston Scientific position as of Q2 2026 after selling out during the quarter.
  • Park Edge Advisors sold 16,958 Boston Scientific shares in Q2 2026, an estimated $1.06M.
  • Park Edge Advisors first reported a position in Boston Scientific in Q4 2022 and held it in 4 quarters.
  • Park Edge Advisors's Boston Scientific position peaked at $1.06M in Q1 2026.
  • 179 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Park Edge Advisors's 13F filing for Q2 2026, filed 13 Jul 2026.